---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-24-113553"
form_type: "8-K"
ticker: "NWBO"
cik: "0001072379"
company_name: "NORTHWEST BIOTHERAPEUTICS INC"
filed_at: "2024-11-01T23:59:59+00:00"
generated_at: "2026-05-30T06:48:11.533239+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Northwest Biotherapeutics enters $5M convertible note with 11% interest, 24-month maturity

## Summary
- Company entered $5,000,000 convertible note with an unrelated shareholder on Oct 31, 2024.
- Note matures in 24 months with no payments due until maturity; interest at 11% per annum.
- Holder can convert into common stock at $0.30/share or non-dilutive financial instrument priced at $50,000.
- Proceeds will be used for ongoing business operations; customary default provisions apply.

## SEC filing metadata
- accession: 0001104659-24-113553
- form_type: 8-K
- ticker: NWBO
- cik: 0001072379
- company_name: NORTHWEST BIOTHERAPEUTICS INC
- filed_at: 2024-11-01T23:59:59+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 2.03
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1072379/000110465924113553/0001104659-24-113553-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1072379/000110465924113553/tm2420750d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-24-113553
- JSON: https://secwatch.observer/filing/0001104659-24-113553.json
- Plain text: https://secwatch.observer/filing/0001104659-24-113553.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.